Skip to main content
SpringerLink
Log in

Current progress on internal medicine in China—2006 Part II

  • Review Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

A lot of progress has been made on internal medicine in the past year. Here a great deal of data were collected about internal medicine in China by searching for some most important medicine magazines published in China in 2006. Because there are so many articles on internal medicine, some representative reports were selected and further reviewed. In the part II, a summary of advances made in four branches includes nephrology, hematology, endocrinology and metabolism, rheumatology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chen X M, Xie Y S. Annual meeting summary of nephrology disease in China in 2006. Zhonghua Yi Xue Za Zhi, 2006, 86(48): 3,453–3,454 (in Chinese)

    Google Scholar 

  2. Zhang L X, Zuo L, Xu G B, Wang F, Wang S Y, Wang M, Lv J C, Zhang J R, Liu L S, Wang H Y. Community-based screening for chronic kidney disease among population older than 40 years in Beijing. Zhonghua Shenzangbing Za Zhi, 2006, 22(2): 67–71 (in Chinese)

    Google Scholar 

  3. Chinese eGFR Investigation Collaboration. Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease Chinese. Zhonghua Shenzangbing Za Zhi, 2006, 22(10): 589–595 (in Chinese)

    Google Scholar 

  4. Liang X L, Shi W, Peng Y Q, Zeng H K, Li H, Zeng F F, Ye Z M, Liu S X, Wang W J. Prospective study of the early diagnosis value for cystatin C in acute renal failure. Zhonghua Shenzangbing Za Zhi, 2006, 22(2): 76–79 (in Chinese)

    CAS  Google Scholar 

  5. Wang Z H, Chen N, Wang W M, Pan X X, Chen X N, Zhang W, Lu Y, Han B. Search and confirmation of single nucleotide polymorphism in susceptibility genes for IgA nephropathy. Zhonghua Shenzangbing Za Zhi, 2006, 22(5): 282–285 (in Chinese)

    Google Scholar 

  6. Ma X Z, Zhang H, Wang S X, Chen Y Q, Hou P, Lv J C, Wang H Y. Clinical characteristics of IgA nephropathy patients with TGBM and the linkage analysis of COL4A3/COL4A4 gene. Zhonghua Shenzangbing Za Zhi, 2006, 22(5): 261–265 (in Chinese)

    CAS  Google Scholar 

  7. Pan X X, Chen N, Zhou W, Wang Z H, Zhang W, Wang W M, Chen X N, Wu Y R, Lu Y. CD2AP mutation in patients with focal segmental glomerulosclerosis. Zhonghua Shenzangbing Za Zhi, 2006, 22(1): 13–18 (in Chinese)

    Google Scholar 

  8. Chen S, Liu Z H, Wang R S, Sun H, Chen D, Chen Z H, Li L S. Phenotype-based glomerular gene expression profiling of patients with diabetic nephropathy. Zhonghua Shenzangbing Za Zhi, 2006, 22(9): 528–534 (in Chinese)

    CAS  Google Scholar 

  9. Wang Y N, Liu H L, Sun Y, Liu Q. Association of intercellular adhesion molecule-1 gene K469E polymorphism to type 2 diabetic nephropathy. Zhonghua Shenzangbing Za Zhi, 2006, 22(4): 201–204 (in Chinese)

    CAS  Google Scholar 

  10. Zhu W, Zhu T Y, You L, Gu Y, Lin S Y. Study on the antioxidative effect of losartan at increasing dose in diabetic nephropathy. Zhonghua Shenzangbing Za Zhi, 2006, 22(4): 193–196 (in Chinese)

    CAS  Google Scholar 

  11. Liu L Y, Zou D J, Zhang J. Association between NADPH oxidize subunit p22phox gene polymorphism and type 2 diabetic nephropathy patients in Shanghai. Zhonghua Shenzangbing Za Zhi, 2006, 22(2): 84–87 (in Chinese)

    Google Scholar 

  12. Wang W X, La W P, Bao Y Q, Lu J X, Lu H J, Zuo Y H, Du J, Liu L H, Fang R, Xiang K S. Chronic renal disease in diabetic and prediabetic subjects: A community-based study in Shanghai. Zhonghua Yi Xue Za Zhi, 2006, 86(36): 2,527–2,532 (in Chinese)

    CAS  Google Scholar 

  13. Zhang W L, Mei C L. Genetic heterogeneity and phenotypes of autosomal dominant polycystic kidney disease in Chinese Han nationality. Zhonghua Yi Xue Za Zhi, 2006, 86(22): 1,516–1,521 (in Chinese)

    CAS  Google Scholar 

  14. Rong S, Mei C L, Jin X C, Jiang H, Niu X P. Morphologic, mechanical and functional sonographic parameters of arteries in autosomal dominant polycystic kidney disease. Zhonghua Shenzangbing Za Zhi, 2006, 22(8): 454–457 (in Chinese)

    Google Scholar 

  15. Xiao H Q, Peng Y M, Liu H, Huang A L, Liu F Y. Renal function at the initiation of dialysis in 514 patients and analysis of correlative factors. Zhonghua Shenzangbing Za Zhi, 2006, 22(3): 153–157 (in Chinese)

    CAS  Google Scholar 

  16. Chen X G, Wu H, Mao Y H, Wang M. Assessment of serum cardiac troponin T and C-reactive protein in predicting hemodialysis outcome. Zhonghua Shenzangbing Za Zhi, 2006, 22(3): 161–165 (in Chinese)

    Google Scholar 

  17. Guo Q Y, Chen L, Yang X, Yang N S, Feng M, Jiang Z P, Mao H P, Chen W, Yu X Q. Characteristics of infecting pathogens and their antimicrobial susceptibilities in peritoneal dialysis related peritonitis: Report of related episodes in a medical center over fifteen years. Zhonghua Shenzangbing Za Zhi, 2006, 22(12): 719–724 (in Chinese)

    CAS  Google Scholar 

  18. Chen W, Jiang Z P, Zheng X H, Chen W Y, Guo Q Y, Mao H P, Ye X Q, Yang X, Yu X Q. Prospective randomized controlled trial of antibiotic prophylaxis for newly placed peritoneal dialysis catheter to prevent postoperative peritonitis and wound infection. Zhonghua Shenzangbing Za Zhi, 2006, 22(10): 601–604 (in Chinese)

    Google Scholar 

  19. Zhou Z, Li J Y. Meeting summary of the ninth Chinese national hematology. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(12): 857–858 (in Chinese)

    CAS  Google Scholar 

  20. Huang R H. Brief introduction of the ninth Chinese national hematology. New Medicine, 2006, 38(2): 140

    Google Scholar 

  21. Xu L P, Huang X J, Liu K Y, Chen H, Liu D H, Han W, Chen Y H, Gao Z Y, Lu J, Wang J Z, Lu D P. Allogeneic stem cell transplantation from genotypically HLA.identical siblings for 30 patients with myelodysplastic syndromes. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(8): 518–521 (in Chinese)

    PubMed  Google Scholar 

  22. Hu L D, Chen H, Jiang M, Li B T, Qin M Q, Yu Z Y, Li Y H. Effectiveness analysis of allogeneic peripheral blood stem cell transplantation in 23 patients with myelodysplastic syndromes. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(8): 522–524 (in Chinese)

    PubMed  Google Scholar 

  23. Zhang Y Z, Da W M, Zhang B L, Gao C J, Han X P, Huang W R, Jing Y, Li H H, Zhao Y, Bo J, Wang S H, Zhu H Y, Jin H J. Clinical study on pulmonary complications after allogeneic peripheral blood stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(6): 366–369 (in Chinese)

    CAS  PubMed  Google Scholar 

  24. Jing Y, Gao C J, Da W M, Tang C J. First case of unrelated donor allogeneic peripheral blood stem cell transplantation in the treatment of severe aplastic anemia in China. Junyi Jinxiu Xueyuan Xuebao, 2006, 27(5): 334–336 (in Chinese)

    Google Scholar 

  25. Zhang S J, Li J Y, Shi J Y, Shi Z Z, Gu B W, Bai X T, Zhu Y M, Shen Z X. Study of mutation and single nucleotide polymorphism of PDGFRβ and SHIP gene in acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(6): 383–385 (in Chinese)

    CAS  PubMed  Google Scholar 

  26. Wu Y J, Li J Y, Zhu M Q, Song J H, Zheng W J. Application of a four antibody (cMPO/cCD79α/cCD3/CD45) combination to the diagnosis of acute leukemia expressing cross-lineage antigens. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(7): 449–451 (in Chinese)

    CAS  PubMed  Google Scholar 

  27. The Cooperation Group of Phase II Clinical Trial of Compound Huangdai Tablet. Phase II clinical trial of compound Huangdai tablet in newly diagnosed acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(12): 801–804 (in Chinese)

    Google Scholar 

  28. Jiang Q, Chen S S, Jiang B, Jiang H, Qiu J Y, Liu Y R, Zhang Y, Qin Y Z, Lu Y, Huang X J, Lu D P. Efficacy and safety evaluation of imatinib mesylate for chronic granniocytic leukemia patients in chronic phase: A 4.5-year follow-up of 100 cases. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(11): 721–726 (in Chinese)

    Google Scholar 

  29. Sino-US Leukemia Cooperative Group of Shanghai. Cytogenetic study on 155 cases of non-Hodgkin’s lymphoma. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(5): 318–322 (in Chinese)

    Google Scholar 

  30. Li J F, Liu W P, Li G D, Tang Y, Liao D Y. Clinico-pathological analysis of 188 cases of bone marrow involvement of lymphoma. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(1): 36–41 (in Chinese)

    PubMed  Google Scholar 

  31. Zhang Y F, Ren Z M, Wu Q L, He Z Y, Huang Y, Xia Y F, Lin T Y, Cui N J. Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(4): 217–221 (in Chinese)

    PubMed  Google Scholar 

  32. Yao B, Li Y X, Fang H, Yu Z H, Jin J, Liu X F. Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(4): 222–225 (in Chinese)

    PubMed  Google Scholar 

  33. Fu G, Lai J Q, Chen C M. Study on the effect of malnutrition and anemia identified among general population in 2002 to the future productivity in China. Zhonghua Liu Xing Bing Xue Za Zhi, 2006, 26(8): 651–654 (in Chinese)

    CAS  Google Scholar 

  34. Xing L M, Shao Z H, Liu H, Shi J, Bai J, Wang H Q, Tu M F, Sun J. The clinical features of the autoimmune hemolytic anemia with both warm and cold autoantibodies. Zhonghua Xue Ye Xue Za Zhi, 2006, 27(1): 42–44 (in Chinese)

    PubMed  Google Scholar 

  35. Tong S T, Lei H Z, Zhou Z Q. Research of screen diagnosis of thalassemia in fetus and neonate of the passed ten years in the region of Qingyuan. Xiandai Yufang Yi Xue, 2006, 33(6): 891–892 (in Chinese)

    Google Scholar 

  36. China Heart Survey Group. Cross-sectional study on the prevalence of abnormal glucose metabolism in patients with coronary artery disease in China—China Heart Survey. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(1): 7–10 (in Chinese)

    Google Scholar 

  37. Song X R, Jin Q L, Wang X Q. Analysis of the two-year outcome of subjects in epidemiologic survey on diabetes in Pingliang community of Shanghai. Zhongguo Tangniaobing Za Zhi, 2006, 14(6): 425–426 (in Chinese)

    Google Scholar 

  38. Hong J, Gu W Q, Zhang Y F, Yang Y S, Shen C F, Gui M H, Wang W Q, Zhao Y J, Ning G. Insulin sensitivity and first-phase insulin secretion in obese subjects with impaired glucose regulation in Shanghai. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(4): 347–350 (in Chinese)

    CAS  Google Scholar 

  39. Zhou P, Y D, Zhang Y, X Y, Cui W J, Atahan K, Miguli K, Guan Y Z, Meng K, Li X G, Wang X H, Zhu D L, Chen N H. Prevalence of abnormal glucose metabolism in population of different ethnics in Ili Prefecture. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(4): 351–353 (in Chinese)

    Google Scholar 

  40. Zhang T M, Zeng P, Han Y W. Prevalence of metabolic syndrome in the city of Beijing. Zhonghua Neifenmi Daixie Za Zhi, 2006, 14(5): 349–352 (in Chinese)

    Google Scholar 

  41. Wei A S, Chen P, Wang F N. A ten-year follow-up study on the patients with impaired glucose tolerance in Foshan City. Zhongguo Tangniaobing Za Zhi, 2006, 14(6): 427–428 (in Chinese)

    Google Scholar 

  42. Wu G, Li G, Luo T H. The association of single nucleotide polymorphism (SNP) of tyrosine kinase gene with type 2 diabetes mellitus. Zhongguo Tangniaobing Za Zhi, 2006, 14(5): 342–345 (in Chinese)

    CAS  Google Scholar 

  43. Qu R, Bai R, Xing Q, Du J L, Sun L P, Sun G H, Ba Y, Yang Y, Li C C. Association of the mitochondrial DNA 16189 T to C variant with early period of atherosclerosis in patients with type 2 diabetes mellitus. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(4): 354–355 (in Chinese)

    CAS  Google Scholar 

  44. Ling D Y, Tang Z Y, Zhang W, Wu J C, Hou R F, Li X Y, Wang W Q, Ning G. Risk factors for cardiovascular autonomic neuropathy and their prognostic implications in type 2 diabetes mellitus. Zhonghua Nei Ke Za Zhi, 2006, 45(10): 815–819 (in Chinese)

    CAS  PubMed  Google Scholar 

  45. Su S O, Zhao J J, Zhang J, Zou D F, Li H, Sheng Z Y, Hang G X, Harald L. Efficacy, safety and acceptance of Acarbose treatment under day-to-day clinical practice conditions: Post-Marketing Surveillance in Chinese type 2 diabetic patients. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(6): I0001–I0005 (in Chinese)

    Google Scholar 

  46. Wu Y J, Wang Y F, Yang H T, Huang Y H, Dong W P. Application of glucosidorum tripterygii tororum as an immune intervention therapy in patients with type 1 diabetes mellitus. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(4): 342–346 (in Chinese)

    CAS  Google Scholar 

  47. Teng W P. Iodine supplementation had better be conducted by localization and individualization. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(6): 510–511 (in Chinese)

    Google Scholar 

  48. Teng X C, Teng D, Shan Z Y, Guan H X, Li Y S, Yu X H, Fan C L, Cong W, Yang F, He L, Liu H, Wen S C, Dm H, Mao J Y, Gu X L, Yu Y, Li J, Chen Y Y, Zhao D, Yang R, Jiang Y Q, Li C Y, Teng W P. Impact of iodine intake on thyroid disease—A five-year prospective epidemiological study. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(6): 512–517 (in Chinese)

    CAS  Google Scholar 

  49. Yao B, Hao L M, Yan J H, Weng J P, Li Y B. Association between the CTLA-4 gene polymorphism and Graves’ disease in the Southern Chinese Han population. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(4): 363–364 (in Chinese)

    CAS  Google Scholar 

  50. Zhang H Q, Zhao J J, Zhao Y R, Liang J, Song H D, Gao L. Association of killer cell immunoglobulin-like receptor gene polymorphisms with Graves’ disease. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(2): 130–131 (in Chinese)

    Google Scholar 

  51. Gao Y, Zhao M H, Ye H, Guo X H. Clinical characteristics of nineteen vasculitis patients associated with propylthiouracil-induced antineutrophil cytoplasmic antibody. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(2): 124–126 (in Chinese)

    Google Scholar 

  52. Zhao D S, Kong F Z, Si H W, Zhu Y K. 131I treatment of hyperthyroidism in children and adolescents. Zhonghua Neifenmi Daixie Za Zhi, 2006, 22(6): 566–568 (in Chinese)

    CAS  Google Scholar 

  53. Zhang F C. Rheumatology in China: Brief introduction of the development of Chinese rheumatology. Rheumatology, 2006, 45(10): 1,323–1,324

    Article  Google Scholar 

  54. Liu X M, Zhao X G, Guo C X, Wei S M. Association between rheumatoid arthritis and shared epitope of HLA-DRB1 gene in Han nationality Neimenggu population. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(11): 668–671 (in Chinese)

    CAS  Google Scholar 

  55. Gao X, Bao L, Wu W, Chen R S, Zhou H Q, LI D M. Cyanogen bromide fragments of type II collagens in rheumatoid arthritis. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(12): 710–712 (in Chinese)

    CAS  Google Scholar 

  56. Zhou J G, Guo X L, Tang Z, Yuan G H, Wei J, Yang M H, He L, Jiang H. Detection and significance of soluble urokinase-type plasminogen activator receptor in plasma and synovial fluid of patients with rheumatoid arthritis. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(12): 713–716 (in Chinese)

    CAS  Google Scholar 

  57. Hou Y, Zhang F C, Huang F, Wu D H, Bao C D, Ni L Q, Yao C. Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized double blind phase III trial in China. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(11): 658–663 (in Chinese)

    Google Scholar 

  58. Wang L S, Huang F, Zhang J L, Zhang L Y, Deng X H, Zhang Y M, Li X F, Guo J H. Risk of tuberculosis in rheumatoid arthritis and ankyiosing spondylitis patients treated with tumor necrosis factor antagonists. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(10): 607–610 (in Chinese)

    Google Scholar 

  59. Pan Z L, Zhang Y C, Sun H S. Erythematosus with HLA-DQA1 in the Han nationality of Chinese in the mainland of China. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(2): 77–81 (in Chinese)

    CAS  Google Scholar 

  60. Tao J H, Li X P, Li X M, Kan M, Zhai Z M, Wang W. Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi, 2006, 86(43): 3,051–3,054 (in Chinese)

    CAS  Google Scholar 

  61. Shen L X, Yu L K, Huang A B, Du R. Study of the clinical features of patients with adolescent-onset systemic lupus erythematosus. Zhonghua Fengshibing Xue Za Zhi, 2006, 10(7): 422–425 (in Chinese)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China

    Yao Dingkang, Zhu Liang, Yu Renqian & Mei Changlin

Authors
  1. Yao Dingkang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhu Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Renqian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mei Changlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mei Changlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, D., Zhu, L., Yu, R. et al. Current progress on internal medicine in China—2006 Part II. Front. Med. China 1, 343–351 (2007). https://doi.org/10.1007/s11684-007-0066-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-007-0066-7

Keywords

Search

Navigation